Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-RRM2 Antibody (R1U21)

Catalog #:   RHD95001 Specific References (29) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IP, WB
Accession: P31350
Overview

Catalog No.

RHD95001

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IP: 1:20, WB: 1:500-1:1000

Target

RR2, Ribonucleotide reductase small chain, Ribonucleotide reductase small subunit, Ribonucleoside-diphosphate reductase subunit M2, RRM2

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P31350

Applications

IF, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1U21

Data Image
  • Immunofluorescence
    Immunocytochemistry analysis of RRM2 (green) in Jurkat using RRM2 antibody,and DAPI(blue).
  • Western blot
    Western blot analysis of RRM2 in K562, Hela lysates using RRM2 antibody.
References

Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses., PMID:38941598

Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer., PMID:37588202

Transcriptomic identification of genes expressed in invasive S. aureus diabetic foot ulcer infection., PMID:37434783

Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo., PMID:37434215

USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2., PMID:37341611

Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM)., PMID:36315425

Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma., PMID:35546399

Identification of RRM2 in peripheral blood mononuclear cells as a novel biomarker for the diagnosis of rheumatoid arthritis., PMID:35200126

microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1., PMID:34968160

CHK1 inhibition exacerbates replication stress induced by IGF blockade., PMID:34773074

Phosphorylated TAR DNA-binding protein-43: Aggregation and antibody-based inhibition., PMID:34339840

Local Deuteration Enables NMR Observation of Methyl Groups in Proteins from Eukaryotic and Cell-Free Expression Systems., PMID:33768661

Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction., PMID:33509941

Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein., PMID:32905837

Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma., PMID:32653773

The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status., PMID:26980146

The immunosuppressant tributyltin oxide blocks the mTOR pathway, like rapamycin, albeit by a different mechanism., PMID:24375594

Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA., PMID:24060417

Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status., PMID:24018362

Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent., PMID:23864387

Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43., PMID:23300771

Gene expression analysis in human breast cancer associated blood vessels., PMID:23056178

Regulation of urokinase expression at the posttranscription level by lung epithelial cells., PMID:22166006

Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma., PMID:20811706

Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS)., PMID:19815002

The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53., PMID:14583450

Cell proteins TIA-1 and TIAR interact with the 3' stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication., PMID:12414941

Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements., PMID:10022872

Direct interaction of the U1 snRNP-A protein with the upstream efficiency element of the SV40 late polyadenylation signal., PMID:7926751

Datasheet

Document Download

Anti-RRM2 Antibody (R1U21).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-RRM2 Antibody (R1U21) [RHD95001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only